Catalog Number 1012462-28 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Non specific EKG/ECG Changes (1817)
|
Event Date 12/07/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that on (b)(6) 2015, the patient presented with a recent non-st elevated myocardial infarction (stemi).A 2.50x28mm absorb bioresorbable vascular scaffold (bvs) was implanted in the 1st diagonal coronary artery lesion, a 2.5x28mm bvs was implanted in the mid left anterior descending (lad) coronary artery lesion, and a 3.0x18mm, 3.0x8mm, and 3.5x12mm bvs were implanted in the proximal lad.Reportedly, there were no device deficiencies.On (b)(6) 2017, the patient was admitted to the hospital with worsening chest pain.Medications were provided.Cardiac labs and a chest x-ray were without positive results.The electrocardiogram displayed prolonged qt interval, and the patient's current medication amitriptyline was reduced.The cardiology team is not reviewing the patient.On (b)(6) 2017, the event resolved and the patient was discharged from the hospital.The study physician was unable to provide a device relationship to the event.There was no additional information provided regarding this issue.
|
|
Manufacturer Narrative
|
(b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of angina, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined and the treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
|
|
Search Alerts/Recalls
|
|